Table: Nippon Shinyaku -2016/17 group results
May 11 (Reuters)-
Nippon Shinyaku Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2017 Mar 31, 2016 Mar 31, 2018 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 98.78 84.21 99.50 47.50
(+17.3 pct) (+5.3 pct) (+0.7 pct) (+6.7 pct)
Operating 15.28 8.55 16.50 6.80
(+78.7 pct) (-0.2 pct) (+8.0 pct) (+4.7 pct)
Recurring 16.24 8.95 17.00 7.00
(+81.4 pct) (+0.3 pct) (+4.7 pct) (+14.2 pct)
Net
Net 11.75 6.34 12.50 5.20
(+85.3 pct) (+7.8 pct) (+6.4 pct) (+16.0 pct)
EPS 174.42 yen 94.10 yen 185.58 yen 77.20 yen
Ann Div 48.00 yen 28.00 yen 50.00 yen
-Q2 Div 18.00 yen 14.00 yen 25.00 yen
-Q4 Div 30.00 yen 14.00 yen 25.00 yen
NOTE - Nippon Shinyaku Co Ltd.
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4516.T
((Tokyo Headline News Desk +813 6441 1812))
Recent news on Nippon Shinyaku
See all newsTable: Nippon Shinyaku -Q1 group results (IFRS)
Brief: Elixirgen Therapeutics And Nippon Shinyaku Enter Into An Option Agreement For The Development And Commercialization Of Exg-7001 For Duchenne Muscular Dystrophy
Table: Nippon Shinyaku -2025/26 group results (IFRS)
Table: Nippon Shinyaku -2025/26 parent results
Table: Nippon Shinyaku -9-MTH group results (IFRS)